Unicycive Therapeutics, Inc. (UNCY)
NASDAQ·Healthcare·Biotechnology
$7.19
-0.55%
Mkt Cap $151.51M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | $517.00K | — | — | -$0.51 | -$0.32 | +37.56% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.59 | -$0.39 | +33.90% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.70 | -$0.52 | +25.71% | — | — |
| Q1 2025 Mar 31, 2025 | — | — | — | -$0.13 | -$0.26 | -100.00% | — | — |
| Q1 2025 Mar 27, 2025 | — | — | — | -$0.13 | -$0.16 | -23.08% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.23 | -$0.15 | +34.78% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.18 | -$0.27 | -50.00% | — | — |
| Q1 2024 Mar 28, 2024 | — | -$271.00K | — | -$0.18 | -$0.16 | +11.11% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.13 | -$0.13 | +0.00% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.39 | -$0.29 | +25.64% | — | — |
| Q2 2023 May 16, 2023 | — | $675.00K | — | -$0.36 | -$0.29 | +19.44% | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | $0.24 | -$0.35 | -245.83% | — | — |
| Q4 2022 Nov 14, 2022 | — | $951.00K | — | -$0.35 | -$0.37 | -5.71% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.27 | -$0.24 | +11.11% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.20 | -$0.24 | -20.00% | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | -$0.13 | -$0.17 | -30.77% | — | — |
| Q4 2021 Nov 11, 2021 | — | — | — | -$0.11 | -$0.37 | -236.36% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$0.11 | -$0.13 | -18.18% | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.11 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.06 | — | — | — |